Shotaro Kamata
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 30, 2025
Peroxisome Proliferator-Activated Receptor α/δ/γ Activation Profile by Endogenous Long-Chain Fatty Acids.Akihiro Honda, Aoi Hosoda, Waka Kamichatani
|Apr 29, 2025
Competitive Ligand-Induced Recruitment of Coactivators to Specific PPARα/δ/γ Ligand-Binding Domains Revealed by Dual-Emission FRET and X-Ray Diffraction of Cocrystals.Shotaro Kamata, Akihiro Honda, Sayaka Yashiro
|Mar 28, 2024
Different Coactivator Recruitment to Human PPARα/δ/γ Ligand-Binding Domains by Eight PPAR Agonists to Treat Nonalcoholic Fatty Liver Disease.Shotaro Kamata, Akihiro Honda, Nonoka Kashiwagi
|Aug 26, 2023
Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor.Shotaro Kamata, Akihiro Honda, Ryo Ishikawa
|Aug 26, 2023
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease.Shotaro Kamata, Akihiro Honda, Isao Ishii
|May 14, 2022
Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate.Akihiro Honda, Shotaro Kamata, Makoto Akahane
Pageof 1
